glp-1 drugs retatrutide Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

Description

Discontinuation was common: 54.2% of the patients in the study data discontinued their GLP-1 RA (30 days without medication on hand), highlighting the need for additional research on the role of shortages, adverse events, and costs

GLP-2 does not increase TRL apoB48 by increasing the synthesis of new particles, nor does it decrease the clearance of TRL apoB48, rather, GLP-2 stimulates the release of pre-formed TRL apoB48 during the first hour of treatment (Dash et al., 2014)

A GLP-1 diet plan is an eating approach designed to work with GLP-1 medications by focusing on the nutrients that matter most when your portions are naturally smaller